Human Cathelicidin Antimicrobial Peptide | Research Grade

LL-37 is the only known human cathelicidin, a 37 amino acid cationic host defence peptide derived from the C-terminal region of the precursor protein hCAP-18. It represents a key component of innate immune defence and has attracted broad research interest for its antimicrobial, immunomodulatory, wound healing, and anticancer properties.

Research Interest Areas: Studied extensively in innate immunity research for broad-spectrum antimicrobial activity against gram-positive, gram-negative bacteria, fungi, and enveloped viruses. Examined in wound healing biology for fibroblast and keratinocyte migration stimulation. Of significant interest in cancer research, particularly for selective cytotoxicity towards certain tumour cell lines in preclinical models. Investigated in autoimmune research for complex dual roles in immune activation and suppression depending on tissue context.

Primary research areas: Innate immunity | Antimicrobial research | Wound healing | Cancer biology | Immunomodulation